Financing

Case Study

Hummingbird Bioscience

• Geller Biopharm was retained to work with Hummingbird Bioscience as its exclusive financial advisor to manage a $100M C round in winter of 2021
• Initial work entailed helping to position the company for institutional investors: assisting in building appropriate materials including, PowerPoint presentation and online data room.
• Arranged over 100 meetings with US, ex-US, and global institutional investors including, venture and crossover funds
• Assisted in finalizing and completing an upsized, several times oversubscribed, $125M financing
• Negotiated a two tranche transaction where both tranches were completed
• This case study demonstrates our ability to successfully complete a large transaction for a company with strong science and management.
• Past performance is not a guarantee of future results